Marco Presta

Title: Marco Presta: Innovator in FGF-Binding Peptides

Introduction

Marco Presta is a notable inventor based in Brescia, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of peptides that interact with growth factors. With a total of 2 patents, his work has implications for medical treatments and therapeutic applications.

Latest Patents

Marco Presta's latest patents include innovative approaches to FGF-binding peptides. The first patent describes FGF2-binding peptides designed from the N-terminal region of PTX, specifically the PTX(-O) region. These synthetic peptides are capable of binding to FGF and inhibiting its pro-angiogenic activity both in vitro and in vivo, without adversely affecting innate immunity. The second patent focuses on the use of the long pentraxin PTX3 for treating diseases caused by altered activation of the growth factor FGF-2. This patent outlines the preparation of a medicament that inhibits the biological activity of FGF-2, which is useful for preventing and treating related diseases.

Career Highlights

Throughout his career, Marco Presta has worked with prominent companies in the pharmaceutical industry, including Tecnogen S.p.a. and Sigma-Tau Industrie Farmaceutiche Riunite S.p.a. His work has been instrumental in advancing therapeutic strategies that target growth factors.

Collaborations

Marco Presta has collaborated with esteemed colleagues such as Marco Rusnati and Maura Camozzi. These partnerships have contributed to the success of his research and innovations.

Conclusion

Marco Presta's contributions to the field of biochemistry, particularly through his patents on FGF-binding peptides, highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.